BNB Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$738K Sell
616
-50
-8% -$51.1K 0.4% 42
2026
Q1
$613K Sell
666
-100
-13% -$101K 0.39% 44
2025
Q4
$823K Buy
+766
New +$732K 0.53% 37

Other funds holding LLY

BNB Wealth Management's LLY Position: Q2 2026 in Review

BNB Wealth Management reduced its Eli Lilly (LLY) stake by 7.5% in Q2 2026, selling an estimated $51.1K and leaving 616 shares worth $738K. The position accounts for 0.4% of the portfolio, ranked #42.

BNB Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $823K in Q4 2025. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BNB Wealth Management held 616 shares of Eli Lilly worth $738K as of Q2 2026.
  • BNB Wealth Management sold 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 0.4% of BNB Wealth Management's portfolio in Q2 2026, its #42 holding.
  • BNB Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • BNB Wealth Management's Eli Lilly position peaked at $823K in Q4 2025.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BNB Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.